This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Icad, Inc.. Active years: 2021-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021-2025
Title: Innovations by Mikael Emil Dan Eriksson
Introduction
Mikael Emil Dan Eriksson is a notable inventor based in Täby, Sweden. He has made significant contributions to the field of medical technology, particularly in breast cancer risk assessment. With a total of two patents to his name, Eriksson's work is focused on improving diagnostic methods through innovative systems.
Latest Patents
One of Eriksson's latest patents is a system and method for assessing breast cancer risk using imagery. This invention provides a comprehensive approach to evaluating the risk of a breast cancer diagnosis based on tissue imagery and other patient-related factors. A computer-aided detection (CAD) system analyzes the imagery and generates a variety of numerical feature values. An assessment module processes inputs from patient factors and history to compute the risk based on these feature values. Additionally, a masking module evaluates the risk of cancers that are typically characterized by a low probability of detection. The system also includes a recall module that generates a computer-aided indication for clinical follow-up, with results displayed to clinicians and patients through a graphical interface.
Career Highlights
Mikael Eriksson is currently employed at iCAD, Inc., a company known for its advanced imaging and cancer detection technologies. His work at iCAD has allowed him to focus on developing innovative solutions that enhance the accuracy of cancer diagnostics.
Collaborations
Eriksson collaborates with several professionals in his field, including Per Frans Leonard Hall and Kourosh Jafari-Khouzani. These collaborations contribute to the advancement of technology in medical imaging and cancer risk assessment.
Conclusion
Mikael Emil Dan Eriksson's contributions to the field of medical technology, particularly in breast cancer risk assessment, highlight the importance of innovation in improving diagnostic methods. His work continues to pave the way for advancements in cancer detection and patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile